ArticlemedRxiv : the preprint server for health sciences2023

Pulmonary function and survival one year after dupilumab treatment of acute moderate to severe COVID-19: A follow up study from a Phase IIa trial.

Jennifer Hendrick et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.